Discussion
Treating multiple myeloma with a Darzalex (daratumumab)-based combination may lead to a faster and longer-lasting response than a standard combination regimen using lenalidomide (sold…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
Discussion
I catch myself smiling at a funny video on my phone while waiting in line at the pharmacy. Almost immediately, I feel a pang of…
Discussion
Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer growth — in people with…
Discussion
The U.S. Food and Drug Administration (FDA) has granted conditional approval to iberdomide, an oral medication to be used in combination with an antibody-based…
Discussion
Remember my great plans to go walking regularly to combat chemo fog? “The best laid schemes o’ Mice an’ Men / Gang aft agley,” wrote…
Discussion
I stand at the kitchen counter chopping vegetables for soup and hear my mum sigh from the living room. One might wonder how I can…
